These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30210001)

  • 1. Crossed Cerebellar Diaschisis in Alzheimer's Disease.
    Reesink FE; García DV; Sánchez-Catasús CA; Peretti DE; Willemsen AT; Boellaard R; Meles SK; Huitema RB; de Jong BM; Dierckx RA; De Deyn PP
    Curr Alzheimer Res; 2018; 15(13):1267-1275. PubMed ID: 30210001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateralization of the crossed cerebellar diaschisis-associated metabolic connectivities in cortico-ponto-cerebellar and cortico-rubral pathways.
    Zhu Y; Ruan G; Cheng Z; Zou S; Zhu X
    Neuroimage; 2022 Oct; 260():119487. PubMed ID: 35850160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossed cerebellar diaschisis in Alzheimer's disease.
    Tripathi SM; Murray AD; Wischik CM; Schelter B
    Nucl Med Commun; 2022 Apr; 43(4):423-427. PubMed ID: 35081090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET/MRI for Visual Detection of Crossed Cerebellar Diaschisis in Patients With Dementia.
    Franceschi AM; Clifton MA; Naser-Tavakolian K; Ahmed O; Bangiyev L; Clouston S; Franceschi D
    AJR Am J Roentgenol; 2021 Jan; 216(1):165-171. PubMed ID: 33170738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossed cerebellar diaschisis on
    Provost K; La Joie R; Strom A; Iaccarino L; Edwards L; Mellinger TJ; Pham J; Baker SL; Miller BL; Jagust WJ; Rabinovici GD
    J Cereb Blood Flow Metab; 2021 Sep; 41(9):2329-2343. PubMed ID: 33691512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
    Bunai T; Kakimoto A; Yoshikawa E; Terada T; Ouchi Y
    J Alzheimers Dis; 2019; 69(2):529-538. PubMed ID: 31104023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
    Kajimoto K; Oku N; Kimura Y; Kato H; Tanaka MR; Kanai Y; Kitagawa K; Maruno M; Yoshimine T; Hori M; Hatazawa J
    Ann Nucl Med; 2007 Feb; 21(2):109-13. PubMed ID: 17424977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
    Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
    Yan L; Liu CY; Wong KP; Huang SC; Mack WJ; Jann K; Coppola G; Ringman JM; Wang DJJ
    Neuroimage Clin; 2018; 17():751-760. PubMed ID: 29527482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
    Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C
    Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.
    Rodriguez-Vieitez E; Carter SF; Chiotis K; Saint-Aubert L; Leuzy A; Schöll M; Almkvist O; Wall A; Långström B; Nordberg A
    J Nucl Med; 2016 Jul; 57(7):1071-7. PubMed ID: 26912447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms, and supratentorial diseases in 26 patients.
    Tien RD; Ashdown BC
    AJR Am J Roentgenol; 1992 May; 158(5):1155-9. PubMed ID: 1566683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 FDG PET demonstrates crossed cerebellar diaschisis 20 years after stroke.
    Shih WJ; Huang WS; Milan PP
    Clin Nucl Med; 2006 May; 31(5):259-61. PubMed ID: 16622331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
    Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
    Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
    Ziolko SK; Weissfeld LA; Klunk WE; Mathis CA; Hoge JA; Lopresti BJ; DeKosky ST; Price JC
    Neuroimage; 2006 Oct; 33(1):94-102. PubMed ID: 16905334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.